# Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections

> **NCT02959957** · PHASE4 · COMPLETED · sponsor: **Håkan Hanberger** · enrollment: 157 (actual)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **DRUG:** Temocillin
- **DRUG:** Cefotaxime

## Key facts

- **NCT ID:** NCT02959957
- **Lead sponsor:** Håkan Hanberger
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-20
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2019-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02959957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02959957, "Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02959957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*